WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for UTHR

Based on 10 analysts offering 12 month price targets for United Therapeutics Corp.
Min Forecast
$203.00-26.61%
Avg Forecast
$277.80+0.43%
Max Forecast
$375.00+35.57%

Should I buy or sell UTHR stock?

Based on 11 analysts offering ratings for United Therapeutics Corp.
Buy
Strong Buy
5 analysts 45.45%
Buy
4 analysts 36.36%
Hold
1 analysts 9.09%
Sell
0 analysts 0%
Strong Sell
1 analysts 9.09%

Be the first to know when Wall Street analysts revise their UTHR stock forecasts and price targets.

UTHR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 16%
85
Strong BuyMaintains$330.00+19.31%2022-12-06
UBS
Bottom 19%
19
Strong BuyInitiates Coverage On$320.00+15.69%2022-12-06
Goldman Sachs
Top 24%
77
Strong SellInitiates Coverage On$230.00-16.85%2022-12-05
JP Morgan
Top 8%
93
Strong BuyMaintains$265.00-4.19%2022-11-03
Oppenheimer
Bottom 11%
11
BuyMaintains$375.00+35.57%2022-11-03
HC Wainwright & Co.
Bottom 5%
5
BuyMaintains$300.00+8.46%2022-11-03
Jefferies
Bottom 9%
9
Strong BuyMaintains$245.00-11.42%2022-05-24
Wedbush
Bottom 13%
13
BuyMaintains$263.00-4.92%2022-05-24
Credit Suisse
Bottom 2%
2
BuyMaintains$247.00-10.70%2022-05-24
Ladenburg Thalmann
Bottom 17%
17
Strong BuyMaintains$203.00-26.61%2022-02-25

1 of 2

Forecast return on equity

Is UTHR forecast to generate an efficient return?
Company
23.17%
Industry
15.35%
Market
62.84%
UTHR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is UTHR forecast to generate an efficient return on assets?
Company
18.28%
Industry
13.55%
UTHR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

UTHR earnings per share forecast

What is UTHR's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$15.21-2.56%
Avg 2 year Forecast
$17.64+13%
Avg 3 year Forecast
$19.30+23.64%
UTHR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

UTHR revenue forecast

What is UTHR's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$1.9B+3.18%
Avg 2 year Forecast
$2.1B+14.62%
Avg 3 year Forecast
$2.3B+25.1%
UTHR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

UTHR earnings growth forecast

How is UTHR forecast to perform vs Biotechnology companies and vs the US market?
Company
7.66%
Industry
7.94%
Market
17.02%
UTHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
UTHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
UTHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

UTHR revenue growth forecast

How is UTHR forecast to perform vs Biotechnology companies and vs the US market?
Company
7.75%
Industry
24.83%
Market
6.69%
UTHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
UTHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

UTHR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
UTHR$276.60$277.80+0.43%Buy
TECH$80.67$461.00+471.46%Buy
NBIX$120.21$122.77+2.13%Buy
SRPT$120.10$144.88+20.63%Buy
JAZZ$149.93$199.00+32.73%Buy

United Therapeutics Stock Forecast FAQ

Is United Therapeutics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: UTHR) stock is to Buy UTHR stock.

Out of 11 analysts, 5 (45.45%) are recommending UTHR as a Strong Buy, 4 (36.36%) are recommending UTHR as a Buy, 1 (9.09%) are recommending UTHR as a Hold, 0 (0%) are recommending UTHR as a Sell, and 1 (9.09%) are recommending UTHR as a Strong Sell.

If you're new to stock investing, here's how to buy United Therapeutics stock.

What is UTHR's earnings growth forecast for 2022-2024?

(NASDAQ: UTHR) United Therapeutics's forecast annual earnings growth rate of 7.66% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

United Therapeutics's earnings in 2022 is $707,400,000.On average, 6 Wall Street analysts forecast UTHR's earnings for 2022 to be $693,225,470, with the lowest UTHR earnings forecast at $602,983,101, and the highest UTHR earnings forecast at $744,727,428. On average, 6 Wall Street analysts forecast UTHR's earnings for 2023 to be $803,977,469, with the lowest UTHR earnings forecast at $678,185,076, and the highest UTHR earnings forecast at $877,356,365.

In 2024, UTHR is forecast to generate $879,635,212 in earnings, with the lowest earnings forecast at $790,760,152 and the highest earnings forecast at $971,700,659.

What is UTHR's revenue growth forecast for 2022-2024?

(NASDAQ: UTHR) United Therapeutics's forecast annual revenue growth rate of 7.75% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.83%, and while it is forecast to beat the US market's average forecast revenue growth rate of 6.69%.

United Therapeutics's revenue in 2022 is $1,860,000,000.On average, 5 Wall Street analysts forecast UTHR's revenue for 2022 to be $87,467,097,037, with the lowest UTHR revenue forecast at $86,147,279,603, and the highest UTHR revenue forecast at $91,616,969,853. On average, 5 Wall Street analysts forecast UTHR's revenue for 2023 to be $97,164,232,078, with the lowest UTHR revenue forecast at $92,366,254,976, and the highest UTHR revenue forecast at $102,409,592,560.

In 2024, UTHR is forecast to generate $106,051,054,454 in revenue, with the lowest revenue forecast at $99,225,586,553 and the highest revenue forecast at $117,474,598,935.

What is UTHR's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: UTHR) forecast ROA is 18.28%, which is higher than the forecast US Biotechnology industry average of 13.55%.

What is UTHR's Price Target?

According to 10 Wall Street analysts that have issued a 1 year UTHR price target, the average UTHR price target is $277.80, with the highest UTHR stock price forecast at $375.00 and the lowest UTHR stock price forecast at $203.00.

On average, Wall Street analysts predict that United Therapeutics's share price could reach $277.80 by Dec 6, 2023. The average United Therapeutics stock price prediction forecasts a potential upside of 0.43% from the current UTHR share price of $276.60.

What is UTHR's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: UTHR) United Therapeutics's current Earnings Per Share (EPS) is $15.61. On average, analysts forecast that UTHR's EPS will be $15.21 for 2022, with the lowest EPS forecast at $13.23, and the highest EPS forecast at $16.34. On average, analysts forecast that UTHR's EPS will be $17.64 for 2023, with the lowest EPS forecast at $14.88, and the highest EPS forecast at $19.25. In 2024, UTHR's EPS is forecast to hit $19.30 (min: $17.35, max: $21.32).

What is UTHR's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: UTHR) forecast ROE is 23.17%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.